Laurus Labs more than doubled its Q2 net profit as revenue rose 33.5% and EBITDA surged 86.3%. Jefferies raised its target price to Rs 2,100, while Kotak and Goldman Sachs retained Sell ratings, citing valuation concerns despite improving growth prospects.
Laurus Labs more than doubled its Q2 net profit as revenue rose 33.5% and EBITDA surged 86.3%. Jefferies raised its target price to Rs 2,100, while Kotak and Goldman Sachs retained Sell ratings, citing valuation concerns despite improving growth prospects.
<iframe src="https://hindustansphere.com/embed/cluster/26d0feb90916942394b4bbebcb82712f54904845" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Laurus Labs Q2 Review: Brokerages Split As Jefferies Raises Target, Two Retain Sell"></iframe>
